Ronald Harty
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $4.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 22, 2022 | NIH | STTR Phase I Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), | $599K | FOX CHASE CHEMICAL DIVERSITY CENTER INC. with UNIVERSITY OF PENNSYLVANIA |
| Apr 1, 2021 | NIH | STTR Phase II Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses | $3.0M | FOX CHASE CHEMICAL DIVERSITY CENTER INC. with UNIVERSITY OF PENNSYLVANIA |
| Jun 1, 2018 | NIH | STTR Phase I Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses | $597K | FOX CHASE CHEMICAL DIVERSITY CENTER INC. with UNIVERSITY OF PENNSYLVANIA |
| Mar 1, 2015 | NIH | STTR Phase I DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSES | $300K | FOX CHASE CHEMICAL DIVERSITY CENTER INC. with UNIVERSITY OF PENNSYLVANIA |
Peer ranks
Federal funding#316
Awards as PI#566
Patents#273
Companies
- FOX CHASE CHEMICAL DIVERSITY CENTER INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.